There are some big picture changes underway driving GSK's upbeat stance on adult immunization. With a population of about 1.43bn and improving life expectancy in India, the preventive medicine theme is gaining traction, including on the policy front.

The manufacturers are exporting the Cough Syrup to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland, the requirement of testing from the laboratories may be waived off, in view of approval granted by these countries regulatory agencies for plants or section engaged in manufacturing and export of Cough Syrup, said in a notification by DGFT.